INS and type 1 diabetes mellitus: Similarly, Henry et al randomly assigned 70 adults with type 1 diabetes (HbA1c 53–86 mmol/mol [7–10%]), stabilised on insulin, to receive dapagliflozin (1, 2.5, 5 or 10 mg) or placebo over 2 weeks [22].